Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaro Andalan Indonesia Tbk. (AADI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Adaro Andalan Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Adaro Andalan Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Adaro Andalan Indonesia Tbk. trades at Rp9,050 (market cap 72.81T, 9.03M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Adaro Andalan Indonesia Tbk. is far larger — about 114.5× UBC Medical Indonesia Tbk.'s market cap, and Adaro Andalan Indonesia Tbk. is more actively traded (9.03M versus 843K). Which is the better fit depends on your goals.

AADILABS
Market Cap
72.81T635.95B
Volume
9.03M843K
Lot
90.33K8.43K
Turnover
82.2B137.6M
Average Price
9,100.43163.22
Value
82.2B137.6M
Indicative Equilibrium Price
9,050165
Indicative Equilibrium Volume
1.54K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AADI
View details
LABS
View details

About Adaro Andalan Indonesia Tbk.

PT Adaro Andalan Indonesia Tbk (formerly PT Alam Tri Abadi) (Company) was established based on Notarial Deed No. 2 which was made in the presence of Ir. Rusli, S.H., Notary in Bekasi, dated December 1, 2004.

Read more on AADI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS